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Abstract
Background: In-vitro fertilization (IVF) is the treatment of choice for unresolved infertility. It comprises a number of
key steps, each of which has to be negotiated before the next is attempted, but the factors which are associated with
failure at each stage have not been reported.
Methods and Findings: We analyzed anonymised national data on women undergoing their first fresh autologous
IVF and intracytoplasmic sperm injection (ICSI) cycle in the United Kingdom between 2000 and 2007 to predict
factors associated with overall lack of livebirth as well as the chance of non-progress at different stages of an IVF
cycle. A total of 121,744 women were included in this analysis. Multivariable models underlined the importance of
increased female age and duration of infertility, lack of previous pregnancy, and a diagnosis of tubal or male factor
infertility in predicting the risk of not having a live birth in an IVF treatment. At each stage, a woman’s chance of
proceeding to the next stage of IVF treatment is affected by increased age and duration of infertility. The intention to
use intra-cytoplasmic sperm injection (ICSI) is associated with a decreased risk of treatment failure in women starting
an IVF cycle (RR 0.93, 99% CI 0.92, 0.94) but this association is reversed at a later stage once fertilisation has been
confirmed (RR=1.01, 99%CI 1.00, 1.03).
Conclusions: Female age is a key predictor of failure to have a livebirth following IVF as well as the risk of poor
performance at each stage of treatment. While increased duration of infertility is also associated with worse
outcomes at every stage, its impact appears to be less influential. Women embarking on ICSI treatment for male
factor infertility have a lower chance of treatment failure but this does not appear to be due to increased chances of
implantation of ICSI embryos.
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Introduction
In-vitro fertilization (IVF) is the recommended treatment of
choice for unresolved infertility (NCCWCH NICE, 2013). In
2011, over 48,147 women in the United Kingdom underwent a
total of 61,726 cycles of IVF or intracytoplasmic sperm injection
(ICSI) (HFEAhttp://www.hfea.gov.uk).
A number of studies in the literature have explored the
impact of factors predicting the successful outcome of IVF in
terms of pregnancy and/or livebirth. Most have relied on
analyses of routinely collected data based on cycles of
treatment and the number of co-variates have been in inverse
proportion to the size of the dataset [1-17]. While factors
depending on ovarian function such as female age and number
of oocytes as well as duration of infertility which is also
associated with female age have been identified as predictors
of pregnancy, a systematic review of studies called for further
research in this area[17].
The Human Fertilisation and Embryology Authority (HFEA)
has collected data on all licensed fertility treatments in the UK
since 1991. Analysis of IVF and ICSI cycles from different time
periods within this dataset by Templeton[18], and Nelson [15]
has identified predictors of livebirth following IVF. Both studies
identified female age, duration of infertility and previous
pregnancy as key prognostic factors. In addition, Nelson and
Lawlor, working with a larger, more recent dataset including
ICSI as well as IVF cycles, found cause of infertility and the use
of ICSI to be additional factors associated with successful
treatment.
Both studies used cycles, rather than individual women as
their unit of analysis, and focused on a global prediction of live
birth. IVF comprises a number of key stages - including
controlled ovarian stimulation oocyte retrieval, fertilisation,
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embryo transfer and confirmation of early pregnancy - each of
which has to be negotiated before the next can be attempted.
With a reported U.K. national live birth rates of 32%
(HFEAhttp://www.hfea.gov.uk) in women aged 18-34 years, the
majority of IVF attempts are not successful. Couples and
clinicians are interested in understanding reasons for treatment
failure and the role of clinical characteristics associated with
non-progress to the next stage but none of the studies in the
literature has addressed this. Additionally, recent years have
seen the emergence of term singleton live birth[19] as a
preferred outcome of IVF, but one which is infrequently
reported by existing prognostic models.
The HFEA data set remains a rich source of material for
investigating factors influencing the overall outcome of IVF as
well as at each stage. In this study, using HFEA data from
women in their first IVF cycles, we aimed to determine the
chance of treatment failure (defined as absence of livebirth and
term singleton livebirth) in women attempting IVF for the first
time and to determine factors associated with the inability to
progress on to the next stage of IVF. We also investigated the
changes in the risk of unsuccessful treatment at each stage of
treatment.
We analyzed anonymised HFEA data (http://
www.hfea.gov.uk) from 2000 to 2007 on women undergoing
their first fresh IVF and ICSI cycles using their own eggs. We
estimated factors associated with global treatment failure as
well as poor outcomes at each stage of an IVF cycle.
Methods
Patients
We utilised anonymised data from the HFEA register and
included all cycles where women were undergoing their first,
fresh, autologous IVF and ICSI cycles between January 2000
and December 2007. We excluded cycles involving egg
donation or those initiated with the express purpose of storage
of eggs/embryos rather than fresh embryo transfer. (Figure 1).
Restricting the analysis to first cycles enabled us to report rates
of failure per individual woman.
Outcomes
Poor ovarian response was defined as retrieval of three or
less oocytes per woman[20] . In women who had eggs mixed
or injected with sperm, poor fertilisation was defined as
fertilisation of fewer than 20% of oocytes. In women who
reached embryo transfer, failure to achieve pregnancy was
defined as a negative pregnancy test. Live birth was defined as
at least one baby born alive and a term singleton live birth was
defined as a single baby born at or beyond 37 weeks gestation.
Covariates
Duration and cause of infertility were categorised in
accordance with previous analyses of HFEA data[15]. Previous
pregnancy related to whether the women had primary infertility
or not as recorded in HFEA database. For numbers of embryos
transferred, we combined 3 and 4 embryo transfers into a
single category and the reference category was double embryo
transfer. The number of fresh oocytes retrieved was
categorised into the following groups; 1-4 oocytes, 5-9 oocytes,
10-14 oocytes (reference category), 15-19 oocytes and 20 or
more oocytes. Our choice of categories was informed by
previous work using HFEA data and we choose 10 -14 oocytes
as the reference category based on the assumption that an
optimal outcome could be anticipated in this group[21]. To
reflect embryo quality we derived a variable- embryo utilisation,
defined as the proportion of all embryos created that were
either transferred or frozen. We did not include elective single
embryo transfer (eSET) as a covariate due to very few cases
during this time period, only 63 (0.1%) first cycles during this
period involved eSET.
Statistical analysis
We performed an analysis using data from all women
embarking on their first cycles to assess associations with
failure to achieve a live birth. We examined whether the
association between prognostic factors and failure to achieve
live birth changed over the course of treatment, by fitting the
same model to the sample of women who achieved each stage
in the course of treatment. The analysis at each stage in the
IVF process was based on only those women who had reached
the preceding stage. For example, in the analysis of ovarian
response, all women were included; for fertilisation, the
denominator was all women in whom at least one oocyte was
mixed with sperm, for embryo transfer the denominator was all
women where at least one embryo was created, and for
positive pregnancy test the denominator was all women who
had at least one embryo transferred. By utilising a
prospectively collected database and clearly defining our
cohort for every analyses, we could estimate the risk that a
women would experience each specific outcome.
We examined likelihood of failure and factors associated with
failure overall and at each stage in the IVF cycle using
univariable and multivariable Poisson regressions with robust
error variance[22,23]. Poisson regression was preferred over
logistic regression since many of our outcomes were common
(e.g. failure of pregnancy with fertility treatment (~75%)) and
the odds ratio is known to overstate the risk ratio in these
circumstances[24]. Risk ratios in multivariable models were
adjusted for all other variables in the model. For the outcomes
of fertilisation and positive pregnancy test (2 weeks after
embryo transfer) we stratified the analysis by the method of
fertilisation i.e. IVF or ICSI. In all other analyses, treatment by
IVF or ICSI was included as a covariate. All statistical analyses
were performed using IBM SPSS version 20 (SPSS Inc.). Age
of women at treatment, duration of infertility, number of oocytes
retrieved, number of embryos transferred, embryo utilisation
and outcome were fitted as categorical variables in the
regressions. The extent of missing data was documented. In
multivariable regressions any cycles with incomplete data on
outcome or covariates were excluded from the analysis. As the
anonymised data are freely available on the HFEA website,
formal ethics approval was not required for this analysis.
Factors Associated with Failed IVF Treatment
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Results
Data from 121,744 women undergoing their first cycle of IVF
or ICSI were included in this analysis (Figure 1). Of these,
72,410 women received IVF and 49,334 had ICSI.
Live birth
Of women undergoing their first IVF or ICSI cycles 91,749
(75.4%) did not have a live birth. The factors associated with
an overall unsuccessful treatment outcome were older age,
increasing duration of infertility, no previous pregnancy and
treatment by IVF (Table 1). After adjustment for all other
variables, women were more likely to not have a live birth when
the diagnosis was tubal disease, male factor or a combination
of known factors, in comparison with cases where the cause of
infertility was unexplained. When we examined how the
relationship between these factors and failure to achieve live
birth changed over the course of treatment, the impact of age,
Figure 1.  Description of women at each stage of the IVF treatment process.  
doi: 10.1371/journal.pone.0082249.g001
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duration of infertility and previous pregnancy remained
reasonably constant at all stages (Table 2). However, with
regards to fertilisation by IVF or ICSI, the association with
unsuccessful treatment changed with the stage of treatment.
When all women embarking on IVF or ICSI were considered,
the intention to use ICSI was associated with a decreased risk
of failure (RR 0.93, 99% CI 0.92, 0.94), but following successful
oocyte retrieval, the insemination method was no longer
independently associated with live birth (RR 1.0, 99% CI 0.98,
1.0). In fact, when only women who reached the stage of
fertilisation (embryo creation) or embryo transfer were included
in the analysis, treatment by ICSI was independently
associated with a slight increase in risk of failure to achieve live
birth. The relationship between cause of infertility and
unsuccessful treatment outcome also changed over the course
of treatment. At the start of a treatment cycle, couples with a
diagnosis of male factor only were at an increased chance of
failure (RR 1.05 99% CI 1.03, 1.06) compared to couples with
unexplained infertility (used as the reference category) but this
disappeared at the next stage as women progressed through
the IVF cycle (RR 1.0. 99% CI 0.99, 1.02). The impact of tubal
infertility on the risk of treatment failure continued to grow at
each stage. Poor embryo utilisation (<50% of all embryos
created either transferred or frozen) increased women’s
chance of non-live birth when only women with at least one
embryo transferred were considered.
Table 1. Factors associated with non-live birth in all women starting their first cycle of IVF treatment.
 
Number of women
in each category
Percentage within
each category with no
live birth
Univariable risk ratio of no live
birth (99% CI) P value
Multivariable risk ratio of no live
birth (99% CI) P value2
   N=121, 744 women included inanalysis  
N=108, 889 women included in
analysis1  
All women 121, 744 91,749 (75.4%)     
Women’s age (years)    P<0.001  P<0.001
18-34 63685 70.3% 1.0  1.0  
35-37 28867 75.2% 1.07 (1.06, 1.08)  1.07 (1.06, 1.08)  
38-39 14853 81.6% 1.16 (1.15, 1.17)  1.17 (1.15, 1.18)  
40-42 11140 90.0% 1.28 (1.27, 1.29)  1.29 (1.27, 1.30)  
43-44 2435 97.0% 1.38 (1.37 , 1.40)  1.39 (1.37, 1.41)  
45-50 764 98.2% 1.40 (1.38, 1.42)  1.41 (1.39, 1.43)  
Missing 0      
Duration (years)    P<0.001  P<0.001
<1 2017 67.8% 0.90 (0.86, 0.94)  0.89 (0.85, 0.92)  
1-3 45799 73.5% 0.98 (0.97, 0.99)  0.96 (0.95, 0.97)  
4-6 38029 75.4% 1.0  1.0  
7-9 12835 77.7% 1.03 (1.02, 1.05)  1.03 (1.01, 1.04)  
10-12 6762 78.9% 1.05 (1.03, 1.07)  1.03 (1.01, 1.05)  
>12 6529 81.8% 1.09 (1.07, 1.10)  1.04 (1.02, 1.06)  
Missing 9773 (8.0%)      
Cause of infertility    P<0.001  P<0.001
Tubal disease only 20141 77.5% 1.03 (1.02, 1.04)  1.05 (1.04, 1.07)  
Ovulatory only 8779 77.0% 1.02 (1.01, 1.04)  1.02 (1.00, 1.04)  
Male Factor Only 37448 73.4% 0.98 (1.96, 0.99)  1.05 (1.03, 1.06)  
Unexplained 32629 75.3% 1.0  1.0  
Endometriosis 4097 73.3% 0.97 (0.95, 1.00)  1.0 (0.97, 1.02)  
Cervical Factors only 52 88.5 1.17 (1.03, 1.34)  1.16 (1.01, 1.34)  
Combination of Known
factors 14268 76.1% 1.01 (1.00, 1.03)  1.06 (0.04, 1.07)  
Missing 4330 (3.6%)      
Previous pregnancy    P=0.001  P<0.001
Yes 71683 75.9% 1.0  1.0  
No 50061 75.0% 0.99 (0.98, 1.00)  1.04 (1.03, 1.05)  
Treatment    P<0.001  P<0.001
IVF 72410 77.5% 1.0  1.0  
ICSI 49334 72.3% 0.93 (0.93, 0.94)  0.93 (0.92, 0.94)  
1 Multivariable risk ratio is adjusted for all variables listed in the table
2 P values obtained from multivariable model.
doi: 10.1371/journal.pone.0082249.t001
Factors Associated with Failed IVF Treatment
PLOS ONE | www.plosone.org 4 December 2013 | Volume 8 | Issue 12 | e82249
Table 2. Factors associated with no live birth in women achieving each stage in IVF process.
 
All women starting 1st
cycle
Women who had at least 1
oocyte retrieved
Women with at least 1 embryo
created
Women with at least 1
embryo transferred
Women who had positive
pregnancy test
 
Univariable
RR1
N=121,744
Multivariable
RR (99% CI)
N=108,889
Univariable
RR N=111,
752
Multivariable
RR (99% CI)
N=100, 091
Univariable RR
N=107, 340
Multivariable
RR (99% CI)
N=96, 227
Univariable
RR N=102,
377
Multivariable
RR (99% CI)
N=91, 903
Univariable
RR N=41,221
Multivariable
RR (99%CI)
N=37,018
All women
n(%)
91,749
(75.4%)
81,929
(75.2%)
81,769
(73.2%)
73,142
(73.1% 77,370(72.1%)
69,291
(72.0%)
72,438
(70.8%)
64, 997
(70.7%)
11,466
(27.8%)
10, 276
(27.8%)
Women’s age (years)          
18-34 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
35-37 1.07 (1.06,1.08)
1.07 (1.06,
1.08)
1.07 (1.06,
1.08)
1.07 (1.06,
1.09) 1.07 (1.06, 1.09)
1.07 (1.05,
1.08)
1.09 (1.07,
1.10)
1.07 (1.06,
1.09)
1.15 (1.09,
1.21)
1.14 (1.08,
1.21)
38-39 1.16 (1.15,1.17)
1.17 (1.15,
1.18)
1.17 (1.15,
1.18)
1.18 (1.16,
1.19) 1.17 (1.15, 1.19)
1.16 (1.14,
1.17)
1.19 (1.17,
1.21)
1.16 (1.15,
1.18)
1.43 (1.34,
1.52)
1.43 (1.34,
1.52)
40-42 1.28 (1.27,1.29)
1.29 (1.27,
1.30)
1.30 (1.28,
1.31)
1.31 (1.29,
1.33) 1.31 (1.29, 1.33)
1.28 (1.26,
1.30)
1.34 (1.32,
1.36)
1.28 (1.26,
1.30)
1.91 (1.79,
2.04)
1.83 (1.69,
1.97)
43-44 1.38 (1.37,1.40)
1.39 (1.37,
1.41)
1.42 (1.40,
1.43)
1.43 (1.41,
1.45) 1.43 (1.41,1.45)
1.38 (1.35,
1.40)
1.47 (1.45,
1.49)
1.37 (1.35,
1.40)
2.68 (2.35,
3.06)
2.39 (2.04,
2.80)
45-50 1.40 (1.38,1.42)
1.41 (1.39,
1.43)
1.43 (1.41,
1.46)
1.46 (1.43,
1.49) 1.45 (1.43, 1.48)
1.39 (1.36,
1.42)
1.49 (1.46,
1.52)
1.38 (1.34,
1.41)
2.58 (1.87,
3.55)
2.50 (1.83,
3.43)
Duration
(years)           
<1 0.90 (0.86,0.94)
0.89 (0.85,
0.92)
0.90 (0.86,
0.94)
0.88 (0.85,
0.92) 0.89 (0.85, 0.94)
0.88 (0.84,
0.92)
0.88 (0.84,
0.93)
0.87 (0.83,
0.92)
1.06 (0.92,
1.22)
1.02 (0.88,
1.17)
1-3 0.98 (0.97,0.99)
0.96 (0.95,
0.97)
0.98 (0.96,
0.99)
0.96 (0.95,
0.97) 0.98 (0.97, 0.99)
0.96 (0.95,
0.98)
0.98
(0.97,0.99)
0.96 (0.95,
0.98)
0.98 (0.93,
1.03)
0.95 (0.90,
1.00)
4-6 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
7-9 1.03 (1.02,1.05)
1.03 (1.01,
1.04)
1.03 (1.02,
1.05)
1.03 (1.01,
1.04) 1.03 (1.01, 1.05)
1.02 (1.01,
1.04)
1.03 (1.01,
1.05)
1.02 (1.0,
1.04)
1.10 (1.02,
1.18)
1.06 (0.99,
1.14)
10-12 1.05 (1.03,1.07)
1.02 (1.01,
1.05)
1.05 (1.02,
1.07)
1.03 (1.01,
1.05) 1.05 (1.02, 1.07)
1.02 (1.00,
1.04)
1.05 (1.03,
1.07)
1.02 (1.00,
1.05)
1.15 (1.05,
1.26)
1.09 (0.99,
1.19)
>12 1.09 (1.07,1.10)
1.04 (1.02,
1.06)
1.09 (1.07,
1.11)
1.04 (1.02,
1.06) 1.09 (1.07, 1.11)
1.03 (1.01,
1.06)
1.10 (1.08,
1.12)
1.04 (1.02,
1.06)
1.24 (1.13,
1.36)
1.09 (0.98,
1.20)
Cause of
infertility           
Tubal disease
only
1.03 (1.02,
1.04)
1.05 (1.04,
1.07)
1.03 (1.02,
1.05)
1.06 (1.05,
1.08) 1.04 (1.02, 1.06)
1.07 (1.06,
1.09)
1.04 (1.03,
1.06)
1.08 (1.06,
1.10)
1.09 (1.03,
1.16)
1.15 (1.08,
1.17)
Ovulatory only 1.02 (1.01,1.04)
1.02 (1.00,
1.04)
1.01 (0.99,
1.03)
1.01 (0.99,
1.03) 1.01 (0.99, 1.03)
1.01 (0.99,
1.03)
0.99 (0.97,
1.02)
1.00 (0.98,
1.02)
1.02 (0.94,
1.11)
1.07 (0.98,
1.17)
Male Factor
Only
0.98 (1.96,
0.99)
1.05 (1.03,
1.06)
0.97 (0.97,
0.99)
1.00 (0.99,
1.02) 0.98 (0.97, 0.99)
1.00 (0.98,
1.02)
0.98 (0.97,
0.99)
1.00 (0.99,
1.02)
0.94 (0.89,
0.99)
0.98 (0.91,
1.05)
Unexplained 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Endometriosis 0.97 (0.95,1.00)
1.0 (0.97,
1.02)
0.97 (0.94,
1.0)
1.00 (0.97,
1.02) 0.97 (0.94, 1.00)
0.99 (0.96,
1.02)
0.97 (0.94,
1.00)
1.00 (0.96,
1.03)
0.92 (0.82,
1.04)
0.97 (0.86,
1.10)
Cervical
Factors only
1.17 (1.03,
1.34)
1.16 (1.01,
1.34)
1.19 (1.02,
1.38)
1.19 (1.01,
1.40) 1.19 (1.01, 1.40)
1.21 (1.01,
1.45)
1.20 (0.99,
1.45)
1.20 (0.96,
1.59)
1.34 (0.41,
4.36)
1.49 (0.45,
4.96)
Combination of
Known factors
1.01 (1.00,
1.03)
1.06 (0.04,
1.07)
1.01 (0.99,
1.02)
1.03 (1.01,
1.05) 1.01 (0.99, 1.03)
1.03 (1.01,
1.04)
1.01 (0.99,
1.03)
1.03 (1.01,
1.05)
1.03 (0.96,
1.11)
1.08 (1.00,
1.16)
Previous pregnancy          
Yes 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
No 0.99 (0.98,1.00)
1.04 (1.03,
1.05)
0.99 (0.98,
1.00)
1.03 (1.02,
1.04) 0.99 (0.98, 0.99)
1.03 (1.02,
1.04)
0.98 (0.97,
0.99)
1.03 (1.02,
1.04)
0.90 (0.87,
0.94)
0.99 (0.94,
1.03)
Treatment           
IVF 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
ICSI 0.93 (0.93,0.94)
0.93 (0.92,
0.94)
0.98 (0.97,
0.99)
1.00 (0.98.
1.01) 0.99 (0.98, 1.0)
1.01 (1.00,
1.03)
0.99 (0.98,
1.00)
1.02 (1.00,
1.03)
0.96 (0.92,
1.00)
1.04 (0.98,
1.10)
Factors Associated with Failed IVF Treatment
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Ovarian response
Of all women starting their first IVF treatment cycle, 20,621
(16.9%) had 3 or fewer oocytes retrieved (Table 3). The
proportion of women with few oocytes was strongly influenced
by age, being lowest in 18 - 34 year olds (11.8%) and highest
in those aged over 45 years (51%). The risk of low oocyte yield
was also independently associated with increasing duration of
infertility, no previous pregnancy and women with a diagnosis
of endometriosis, male factor, or anovulation relative to women
with an unexplained diagnosis. Univariately, a diagnosis of
male factor infertility was associated with a reduced risk of low
oocyte yield (RR 0.87, 99% CI 0.83, 0.91), possibly reflecting
the fact that these women tended to be younger. This effect
disappeared once female age and other factors were adjusted
for in the multivariate model (RR 1.98, 99% CI 1.88, 2.09).
Fertilisation in women who had at least one oocyte
mixed with partner sperm
Of all women who started their first IVF cycle, 62,239
(86.0%) had at least one egg inseminated and of all women
who started their first ICSI cycle, 49,119 (99.6%) had at least
one egg injected with sperm. Of these, in the IVF group 2,931
(4.7%) women had failed fertilisation, while the corresponding
figure in the ICSI group was 1,087 (2.2%). Poor fertilisation
(1-19% eggs fertilised) occurred in 2.5% of IVF cycles and
0.9% of ICSI cycles. Table 4 shows univariable and
multivariable associations with failure or poor fertilisation
(<20% of eggs fertilised) stratified by type of treatment. In
women undergoing IVF in their first cycle with at least one
oocyte mixed with partner sperm, the risk of failure or poor
fertilisation increased with increasing duration, for women who
had no previous pregnancy (1.3, 99% CI 1.19, 1.42) and few
(1-4) oocytes retrieved (RR 2.03, 99% CI 1.81, 2.27). A
diagnosis of male factor increased the risk of failed or poor
Table 2 (continued).
 
All women starting 1st
cycle
Women who had at least 1
oocyte retrieved
Women with at least 1 embryo
created
Women with at least 1
embryo transferred
Women who had positive
pregnancy test
 
Univariable
RR1
N=121,744
Multivariable
RR (99% CI)
N=108,889
Univariable
RR N=111,
752
Multivariable
RR (99% CI)
N=100, 091
Univariable RR
N=107, 340
Multivariable
RR (99% CI)
N=96, 227
Univariable
RR N=102,
377
Multivariable
RR (99% CI)
N=91, 903
Univariable
RR N=41,221
Multivariable
RR (99%CI)
N=37,018
Number of oocytes
retrieved          
1-4   1.27 (1.25,1.28)
1.21 (1.19,
1.22) 1.25 (1.23, 1.27)
1.19 (1.17,
1.21)
1.25 (1.23,
1.27)
1.14 (1.12,
1.17)
1.29 (1.20,
1.39)
1.20 (1.11,
1.30)
5-9   1.10 (1.09,1.12)
1.09 (1.07,
1.10) 1.10 (1.09, 1.12)
1.08 (1.07,
1.10)
1.11 (1.09,
1.12)
1.08 (1.07,
1.10)
1.13 (1.08,
1.19)
1.11 (1.05,
1.17)
10-14   1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
15-19   0.99 (0.97,1.00)
1.00 (0.98,
1.02) 0.99 (0.97, 1.01)
1.00 (0.98,
1.02)
0.98 (0.96,
1.0)
0.99 (0.97,
1.01)
1.02 (0.95,
1.09)
1.06 (0.99,
1.13)
20+   1.05 (1.03,1.07)
1.07 (1.05,
1.09) 1.06 (1.04, 1.08)
1.07 (1.05,
1.09)
0.96 (0.93,
0.98)
0.97 (0.95,
1.00)
0.98 (0.91,
1.06)
1.01 (0.93,
1.10)
Num. of embryos
transferred          
One       1.26 (1.25,1.28)
1.17 (1.15,
1.18)
1.24 (1.14,
1.35)
1.17 (1.07,
1.28)
Two       1.0 1.0 1.0 1.0
>Three       1.14 (1.12,1.16)
1.04 (1.03,
1.06)
1.29 (1.20,
1.39)
1.06 (0.98,
1.15)
Embryo
Utilisation2           
0-25%       0.92 (0.91,0.94)
1.03 (1.01,
1.05)
0.98 (0.91,
1.04)
1.05
(0.98.1.13)
25-50%       0.97 (0.96,0.98)
1.02 (1.01,
1.04)
1.03 (0.98,
1.08)
1.05 (0.99,
1.11)
50-75%       0.94 (0.93,0.96)
0.99 (0.98,
1.01)
0.99 (0.94,
1.05)
1.00 (0.94,
1.07)
75-100%       1.0 1.0 1.0 1.00
1 RR - risk ratio
2 Embryo utilisation is defined as (number of embryos transferred + number of embryos frozen)/total number of embryos created
doi: 10.1371/journal.pone.0082249.t002
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fertilisation whilst diagnosis of endometriosis or tubal disease
reduced the risk when compared to women with unexplained
infertility. In women who received ICSI, failed or poor
fertilisation was associated with retrieval of few (1-4) oocytes
(RR 5.29, 99% CI 4.32, 6.51) but not duration or cause of
infertility.
Positive pregnancy test in women who had at least one
embryo transferred
Of women undergoing their first cycle of IVF and ICSI and
having at least one embryo created, 4.9% (2882) and 4.3%
(2081) of women respectively, failed to achieve embryo
transfer. In women who received one or more embryos, similar
proportions of those treated by IVF and ICSI failed to achieve a
positive pregnancy test, 33, 839 (60%) and 27, 317 (59.4%)
respectively.
Multivariable models showed the risk of a negative
pregnancy test 2 weeks after embryo transfer in women who
reached this stage, (using either IVF or ICSI generated
embryos) increased with rising female age. Absence of a
pregnancy was less likely in women with a short duration of
infertility, but more likely in women with no previous pregnancy,
low oocyte yield, poor embryo utilisation (<50%) and transfer of
1, 3 or 4 embryos (as opposed to 2) (Table 5).
Table 3. Factors associated with poor ovarian response in women starting their first cycle of treatment.
 
Poor ovarian response1 N (%)
(N=121,704 women)
Univariable risk ratio of poor
ovarian response (99% CI) P value
Multivariable2 risk ratio of poor ovarian
response (99% CI) (N=108,857 women
included in analysis) P value3
All women 20, 621 (16.9%)   18, 240 (16.8%)  
Women’s age (years)   P<0.001  P<0.001
18-34 7533 (11.8%) 1.0  1.0  
35-37 4832 (16.7%) 1.42 (1.35, 1.48)  1.38 (1.32, 1.44)  
38-39 3406 (22.9%) 1.94 (1.85, 2.03)  1.87 (1.78, 1.97)  
40-42 3442 (30.9%) 2.61 (2.49, 2.73)  2.53 (2.41, 2.66)  
43-44 1018 (41.8%) 3.53 (3.30, 3.78)  3.39 (3.15, 3.65)  
45-50 390 (51.0%) 4.31 (3.92, 4.75)  3.95 (3.50, 4.40)  
Duration (years)   P<0.001  P<0.001
<1 282 (14.0%) 0.86 (0.74, 0.99)  0.81 (0.70, 0.94)  
1-3 7253 (15.8%) 0.97 (0.93, 1.01)  0.93 (0.90, 0.97)  
4-6 6192 (16.3%) 1.0  1.0  
7-9 2311 (18.0%) 1.11 (1.05, 1.17)  1.12 (1.06, 1.18)  
10-12 1308 (19.4%) 1.19 (1.11, 1.28)  1.16 (1.08, 1.24)  
>12 1465 (22.4%) 1.38 (1.29, 1.47)  1.19 (1.11, 1.27)  
Cause of infertility   P<0.001  P<0.001
Tubal disease only 3300 (16.4%) 0.96 (0.91, 1.01)  1.00 (0.95, 1.06)  
Ovulatory only 1945 (22.2%) 1.29 (1.22, 1.37)  1.26 (1.18, 1.34)  
Male Factor Only 5599 (15.0%) 0.87 (0.83, 0.91)  1.98 (1.88, 2.09)  
Unexplained 5594(17.1%) 1.0  1.0  
Endometriosis 757 (18.5%) 1.08 (0.99, 1.18)  1.16 (1.05, 1.27)  
Cervical Factors only 12 (23.1%) 1.35 (0.70, 2.59)  1.21 (0.6, 2.45)  
Combination of Known factors 2586 (18.1%) 1.06 (1.00, 1.12)  1.63 (1.54, 1.73)  
Previous pregnancy   P<0.001  P<0.001
Yes 8800 (17.6%) 1.0  1.0  
No 11821 (16.5%) 0.94 (0.91, 0.97)  1.14 (1.10, 1.18)  
Treatment   P<0.001  P<0.001
IVF 16214 (22.4%) 1.0  1.0  
ICSI 4407 (8.9%) 0.40 (0.38, 0.42)  0.29 (0.27, 0.30)  
Stimulated cycle   P<0.001   
Yes 20094 (16.6%)     
No 527 (93.3%)     
1 Poor ovarian response defined as 3 or less oocytes retrieved. In 40 women information on number of oocytes retrieved was missing.
2 Risk ratio adjusted for all variables listed (except for stimulated cycle where 99% of women included in multivariate model had stimulated cycle).
3 P values obtained from multivariable model.
doi: 10.1371/journal.pone.0082249.t003
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Live birth and singleton term live birth in those with a
positive pregnancy test
A total of 41,221 women had positive pregnancy test. Of
these, 11,466 (27.8%) failed to achieve a live birth and 21,421
(52.0%) failed to achieve a term, singleton live birth (Table 6).
In women who became pregnant, increasing age, diagnosis of
tubal disease, single embryo transfer and low number of
oocytes retrieved were associated with lack of live birth.
Inability to have a singleton livebirth was associated with age
above 40 years, and transfer of 2 or more embryos. Number of
oocytes retrieved, embryo utilisation and treatment by IVF or
ICSI were not associated with lack of term singleton live birth.
Discussion
Principal findings
The results of this study underline the importance of
increased female age and duration of infertility, lack of previous
Table 4. Factors associated with poor fertilisation in women who had at least one oocyte mixed or injected with partner
sperm.
 IVF ICSI
 
Univariable risk ratio of
poor fertilisation1
Multivariable2 risk ratio (99%
CI) of poor fertilisation P value3
Univariable risk ratio of
poor fertilisation1
Multivariable2 risk ratio (99%
CI) of poor fertilisation P value3
 (N=62,239 women) (N=55, 725 women includedin the analysis)  (N=49, 119 women)
(N=44,043 women included
in analysis)  
All women 4500 (7.2%) 4006 (7.2%)  1518 (3.1%) 1321 (3.0%)  
Women’s age (years)   P=0.024   P=0.001
18-34 1.0 1.0  1.0 1.0  
35-37 1.00 (0.91, 1.09) 0.93 (0.85, 1.03)  1.16 (0.98, 1.38) 0.96 (0.80, 1.15)  
38-39 1.02 (0.90, 1.14) 0.90 (0.79, 1.02)  1.64 (1.35, 1.99) 1.19 (0.96, 1.48)  
40-42 1.11 (0.98, 1.26) 0.93 (0.81, 1.07)  2.07 (1.69, 2.54) 1.27 (1.01, 1.59)  
43-44 1.33 (1.05, 1.68) 0.99 (0.76, 1.28)  2.83 (2.00, 4.00) 1.45 (0.99, 2.11)  
45-50 1.96 (1.41, 2.74) 1.35 (0.94, 1.95)  3.79 (2.25, 6.37) 1.65 (0.94, 2.90)  
Duration (years)   P<0.001   P=0.035
<1 0.78 (0.56, 1.07) 0.95 (0.68, 1.31)  0.88 (0.49, 1.58) 0.95 (0.54, 1.68)  
1-3 0.87 (0.79. 0.95) 0.90 (0.82, 0.99)  0.95 (0.81, 1.12) 0.96 (0.81, 1.13)  
4-6 1.0 1.0  1.0 1.0  
7-9 1.15 (1.01, 1.30) 1.24 (1.09, 1.40)  1.12 (0.89, 1.41) 1.09 (0.87, 1.38)  
10-12 1.03 (0.87, 1.22) 1.19 (1.00, 1.41)  1.42 (1.09, 1.85) 1.35 (1.03, 1.77)  
>12 0.99 (0.83, 1.17) 1.19 (0.99, 1.43)  1.21 (0.91, 1.62) 1.06 (0.78, 1.44)  
Cause of infertility   P<0.001   P=0.224
Tubal disease only 0.60 (0.54, 0.67) 0.64 (0.57, 0.71)  1.22 (0.85, 1.75) 1.26 (0.86, 1.85)  
Ovulatory only 1.09 (0.97, 1.23) 1.07 (0.94, 1.21)  1.57 (1.07, 2.30) 1.43 (0.96, 2.13)  
Male Factor Only 1.29 (1.14, 1.47) 1.29 (1.13, 1.48)  1.08 (0.87, 1.34) 1.16 (0.93, 1.45)  
Unexplained 1.0 1.0  1.0 1.0  
Endometriosis 0.75 (0.62, 0.91) 0.71 (0.58, 0.86)  1.08 (0.54, 2.14) 0.92 (0.43, 1.98)  
Cervical Factors only 1.78 (0.67, 4.73) 1.58 (0.55, 4.48)  -4 -4  
Combination of Known
factors 0.93 (0.81, 1.07) 0.94 (0.81, 1.08)  1.14 (0.89, 1.47) 1.17(0.90, 1.52)  
Previous pregnancy   P<0.001   P=0.006
Yes 1.0 1.0  1.0 1.0  
No 1.33 (1.23, 1.43) 1.30 (1.19, 1.42)  0.99 (0.86, 1.13) 1.19 (1.01, 1.39)  
Number of oocytes retrieved  P<0.001   P<0.001
1-4 2.03 (1.83, 2.26) 2.03 (1.81, 2.27)  5.85 (4.83, 7.09) 5.29 (4.31, 6.51)  
5-9 1.10 (0.99, 1.22) 1.09 (0.98, 1.21)  1.49 (1.21, 1.83) 1.40 (1.13, 1.75)  
10-14 1.0 1.0  1.0 1.0  
15-19 0.95 (0.82, 1.09) 0.94 (0.81, 1.09)  0.76 (0.56,1.05) 0.73 (0.54, 1.02)  
20+ 1.10 (0.95, 1.28) 1.08 (0.92, 1.27)  0.81 (0.56, 1.16) 0.82 (0.56, 1.19)  
1 Poor fertilisation defined as failure or less than 20% of oocytes fertilised
2 Multivariable risk ratio is adjusted for all variables listed
3 P values obtained from multivariable model.
4 Women receiving ICSI with cause of infertility recorded as cervical factors only (n=4), were excluded from the analysis
doi: 10.1371/journal.pone.0082249.t004
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pregnancy and tubal and male factor infertility in predicting the
risk of not having a livebirth in an IVF treatment. At each stage,
a woman’s chance of proceeding to the next phase of IVF
treatment is affected by increased age and duration of
infertility. The intention to perform ICSI is associated with a
decreased risk of treatment failure in women starting an IVF
Table 5. Factors associated with failure to achieve positive pregnancy test in women who reached embryo transfer.
 IVF  ICSI  
Characteristic
Univariable risk ratio of non-
positive pregnancy test
(99%CI)
Multivariable risk ratio1 of
non-positive pregnancy test
(99% CI) P value2
Univariable risk ratio of non-
positive pregnancy test
(99%CI)
Multivariable risk ratio1 of
non-positive pregnancy test
(99% CI) P value2
 
N=56, 426 women with at
least one embryo
transferred
(N=50,591 women included
in analysis)  
N=45,951 women with at
least one embryo
transferred
(N=41, 310 women
included in the analysis  
All Women 33,839 (60.0%) 30,336 (60.0%)  27,317 (59.4%) 24,547 (59.4%)  
Women’s age (years)   P <0.001   P<0.001
18-34 1.0 1.0  1.0 1.0  
35-37 1.10 (1.08, 1.13) 1.09 (1.06, 1.11)  1.10 (1.07, 1.13) 1.06 (1.05, 1.09)  
38-39 1.21 (1.18, 1.24) 1.17 (1.14, 1.21)  1.22 (1.18, 1.26) 1.17 (1.13, 1.21)  
40-42 1.40 (1.37, 1.44) 1.33 (1.30, 1.37)  1.41 (1.37, 1.45) 1.30 (1.26, 1.49)  
43-44 1.64 (1.59, 1.69) 1.53 (1.48, 1.59)  1.60 (1,54, 1.67) 1.42 (1.36, 1.49)  
45-50 1.71 (1.64, 1.78) 1.55 (1.47, 1.63)  1.70 (1.62, 1.79) 1.49 (1.40, 1.59)  
Duration (years)   P<0.001   P<0.001
<1 0.78 (0.72, 0.86) 0.78 (0.71, 0.85)  0.80 (0.73, 0.89) 0.80 (0.72, 0.88)  
1-3 0.98 (0.96, 1.00) 0.96 (0.94, 0.98)  0.96 (0.93, 0.98) 0.95 (0.93, 0.97)  
4-6 1.0 1.0  1.0 1.0  
7-9 1.02 (0.99, 1.06) 1.01 (0.98, 1.04)  1.03 (0.99, 1.06) 1.02 (0.98, 1.05)  
10-12 1.04 (1.0, 1.08) 1.01 (0.97, 1.05)  1.05 (1.01, 1.10) 1.03 (0.98, 1.07)  
>12 1.09 (1.05, 1.14) 1.02 (0.98, 1.06)  1.13 (1.08, 1.17) 1.07 (1.02, 1.11)  
Cause of infertility   P<0.001   P=0.002
Tubal disease only 1.05 (1.03, 1.07) 1.10 (1.08, 1.13)  1.07 (1.02, 1.13) 1.09 (1.03, 1.15)  
Ovulatory only 0.98 (0.95, 1.01) 0.98 (0.95, 1.02)  1.02 (0.96, 1.09) 1.00 (0.94, 1.07)  
Male Factor Only 0.95 (0.92, 1.0) 0.98 (0.95, 1.02)  0.98 (0.95, 1.01) 1.01 (0.98, 1.05)  
Unexplained 1.0 1.0  1.0 1.0  
Endometriosis 0.98 (0.94, 1.02) 1.01 (0.67, 1.05)  0.96 (0.86, 1.07) 0.96 (0.86, 1.07)  
Cervical Factors only 1.23 (0.93, 1.64) 1.24 (0.91, 1.70)  -4 -4  
Combination of known
factors 1.01 (0.98, 1.05) 1.05 (1.01, 1.09)  1.00 (0.96, 1.04) 1.01 (0.97, 1.05)  
Previous pregnancy   P<0.001   P<0.001
Yes 1.0 1.0  1.0 1.0  
No 1.01 (0.99, 1.02) 1.05 (1.03, 1.08)  0.99 (0.97, 1.01) 1.05 (1.03, 1.08)  
Number of embryos
transferred   P<0.001   P<0.001
One 1.39 (1.36, 1.41) 1.26 (1.23, 1.29)  1.41 (1.38, 1.44) 1.26 (1.22, 1.29)  
Two 1.0 1.0  1.0 1.0  
Three/four 1.18 (1.15, 1.22) 1.06 (1.03, 1.10)  1.16 (1.12, 1.20) 1.05 (1.01, 1.09)  
Number of oocytes
retrieved   P<0.001   P<0.001
1-4 1.35 (1.31, 1.38) 1.20 (1.16, 1.23)  1.38 (1.34, 1.42) 1.21 (1.17, 1.25)  
5-9 1.13 (1.11, 1.16) 1.11 (1.08, 1.14)  1.15 (1.12, 1.18) 1.11 (1.08, 1.14)  
10-14 1.0 1.0  1.0 1.0  
15-19 0.96 (0.93, 1.0) 0.98 (0.94, 1.01)  0.95 (0.92, 0.99) 0.96 (0.93, 1.00)  
20+ 0.94 (0.90, 0.98) 0.96 (0.92, 1.01)  0.92 (0.88, 0.97) 0.94 (0.90, 0.99)  
Embryo Utilisation3   P<0.001   P=0.002
0-25% 0.90 (0.88,0.93) 1.05 (1.02, 1.09)  0.86 (0.83, 0.89) 1.02 (0.98, 1.06)  
25-50% 0.95 (0.93, 0.97) 1.01 (0.99, 1.04)  0.94 (0.92, 0.99) 1.03 (1.00, 1.06)  
50-75% 0.91 (0.89, 0.93) 0.98 (0.96, 1.01)  0.90 (0.88, 0.93) 0.99 (0.96, 1.02)  
75-100% 1.0 1.0  1.0 1.0  
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cycle but this association is reversed at a later stage once
fertilisation has been confirmed. Other factors such as cause of
infertility, number of oocytes retrieved and number of embryos
replaced also play a role in determining poor intermediate
outcomes.
Strengths
This is the first study to conduct an analysis based on
women as opposed to cycles using a large national IVF
database with total capture of all treatments. It is also the first
to attempt to identify factors affecting global failure as well as
those influencing women’s chances of progressing onto the
next stage of treatment. In recognition of a healthy baby as a
key outcome of IVF, the results include factors which affect the
chance of not having a singleton term livebirth.
Weaknesses
As the study is based on routinely collected data, we were
not able to adjust for a number of known and potential
confounders such as smoking, body mass index and paternal
age which are not captured at all within this dataset. In addition
we were unable to examine the influence of tests of ovarian
reserve or embryo quality as these data are not collected,
although we did attempt to examine embryo quality through our
derived variable embryo utilisation. To maintain confidentiality,
maternal age was only available grouped into categories – this
inevitably impacted on the accuracy of the model to estimate
the effect of increasing age on treatment outcomes. There
were some missing data for some of the variables. In order to
analyse outcomes in women as opposed to cycles we focused
on first cycles only and are therefore unable to identify factors
associated with live births resulting from multiple IVF cycles
including fresh and frozen embryo transfers.
Comparison with results in the published literature
A number of previous studies (including two based on the
HFEA database) have estimated factors affecting outcomes in
IVF[15,18,25]. All have used a cycle based approach and as
the data are not linked to women have been unable to adjust
for the clustering effect of cycles within women. In their
analysis of 36, 961 in-vitro fertilisation (IVF) cycles between
1991 and 1994 Templeton et al. found that livebirth rates were
highest in women aged 25-30 years, with poorer outcomes in
older women[18]. Age adjusted livebirth rates fell with
increasing duration of infertility, but the cause of infertility had
little effect on outcomes. The odds of success were enhanced
by previous pregnancy and livebirth and reduced by one or
more previous failed IVF treatment cycles reduced them.
A more recent study, based on the analysis of HFEA data
between 2003 and 2007, examined the predictors of live birth
in 144,018 IVF and intracytoplasmic sperm injection (ICSI)
cycles[15]. The overall livebirth rate in this cohort was 23.4%
(95% confidence intervals 23.2-23.7). The odds of live birth
following IVF/ICSI were increased by lower female age, shorter
duration of infertility, previous successful IVF treatments, use of
donor oocytes and unexplained infertility. Women who
underwent ICSI had a higher chance of a livebirth compared to
those who had IVF. However, our analyses suggest that in
women who have had oocyte retrieval, treatment by ICSI does
not appear to offer increased benefit and may be actually
associated with failure to achieve live birth. This is likely to be
due to the change in the composition of women who reach the
stage of fertilisation. Many more women whose intention was to
be treated by IVF (13.6%) did not have any oocytes retrieved
compared to those women whose intended treatment was ICSI
(0.3%). This is likely to be due to the fact that many more
women who require IVF may be older and less likely to
respond well to ovarian stimulation compared to women
receiving ICSI. Many in this group are not themselves infertile
but are relatively young partners of men with semen
abnormalities.
Our results, based on the same dataset but using a different
timeframe and adopting a woman based approach, corroborate
the findings of these earlier studies in confirming the pivotal
role of these predictive variables.
A preliminary analysis of these data, to investigate the
factors associated with failure to achieve pregnancy in women
undergoing first IVF and ICSI cycles that reached embryo
transfer [26] adopted a different analytical approach with odds
ratios reported rather than risk ratios. In general, these odds
ratios were substantially larger than the corresponding risk
ratios reported in Table 5, due to the high proportion of women
(60%) who failed to achieve pregnancy following embryo
transfer. In these circumstances where the outcome is
common, the odds ratio is known to overstate the risk ratio [24].
A systematic review of studies by Loendersloot[17] included
a number of prognostic models but did not include the two
studies mentioned above (Templeton and Nelson[15,18]) but
identified others which have generated models for the
prediction of pregnancy following IVF. The outcome in most of
these studies was pregnancy[2-9,11] rather than
livebirth[10,12,14], and the individual papers varied in the
factors identified – possibly because they were based on
routinely collected data and were therefore reliant on the
variables available in the relevant dataset. Aggregation of the
results showed negative associations between the chance of
pregnancy and the following – female age, duration of infertility
Table 5 (continued).
1 Multivariable risk ratio is adjusted for all variables listed
2 P values obtained from multivariable model.
3 Embryo utilisation is defined as (number of embryos transferred + number of embryos frozen)/total number of embryos created
4 Women receiving ICSI with cause of infertility recorded as cervical factors only (n=4), were excluded from the analysis
doi: 10.1371/journal.pone.0082249.t005
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Table 6. Factors associated with non-live birth and non-term singleton live birth in women who achieved a pregnancy.
 Non-live birth Non-singleton term live birth1
 
Univariable risk Ratio of
non-live birth
Multivariable2 risk Ratio of
non-live birth P value3
Univariable risk Ratio of
non-term singleton live
birth
Multivariable2 risk Ratio of
non-term singleton live birth P Value3
 (N=41,221 women) (N= 37,018 women includedin analysis)  (N=41,221 women)
(n=37,018 women included
in analysis)  
All women 11,466 (27.8%) 10,276 (27.8%)  21,421 (52.0%) 19,252 (52.0%)  
Women’s age (years)   P<0.001   P<0.001
18-34 1.0 1.0  1.0 1.0  
35-37 1.15 (1.09, 1.21) 1.14 (1.08, 1.21)  0.96 (0.93, 0.99) 0.96 (0.93, 0.99)  
38-39 1.43 (1.34, 1.52) 1.43 (1.34, 1.52)  0.98 (0.94, 1.02) 0.98 (0.94, 1.02)  
40-42 1.91 (1.79, 2.04) 1.83 (1.69, 1.97)  1.11 (1.05, 1.16) 1.07 (1.01, 1.14)  
43-44 2.68 (2.35, 3.06) 2.39 (2.04, 2.80)  1.39 (1.24, 1.55) 1.29 (1.13, 1.48)  
45-50 2.58 (1.87, 3.55) 2.50 (1.83, 3.42)  1.56 (1.28, 1.91) 1.46 (1.14, 1.87)  
Duration (years)   P<0.001   P<0.001
<1 1.06 (0.92, 1.22) 1.02 (0.88, 1.17)  0.95 (0.87, 1.04) 0.94 (0.86, 1.03)  
1-3 0.98 (0.93, 1.03) 0.95 (0.90, 1.00)  0.97 (0.94, 1.0) 0.96 (0.94, 0.99)  
4-6 1.0 1.0  1.0 1.0  
7-9 1.10 (1.02, 1.18) 1.06 (0.99, 1.14)  1.00 (0.96, 1.05) 1.00 (0.95, 1.04)  
10-12 1.15 (1.05, 1.26) 1.08 (0.99, 1.19)  1.03 (0.98, 1.09) 1.01 (0.96, 1.07)  
>12 1.24 (1.13, 1.36) 1.09 (0.98, 1.20)  1.07 (1.01, 1.14) 1.05 (0.99, 1.12)  
Cause of infertility   P<0.001   P<0.001
Tubal disease only 1.09 (1.03, 1.16) 1.15 (1.08, 1.23)  1.06 (1.03, 1.10) 1.05 (1.01, 1.09)  
Ovulatory only 1.02 (0.94, 1.11) 1.07 (0.98,1.17)  1.06 (1.00, 1.11) 1.05 (1.00, 1.11)  
Male Factor Only 0.94 (0.89, 0.99) 0.98 (0.91, 1.05)  0.96 (0.93, 1.00) 0.97 (0.93, 1.01)  
Unexplained 1.0 1.0  1.0 1.0  
Endometriosis 0.92 (0.82, 1.04) 0.97 (0.86, 1.10)  1.01 (0.94, 1.08) 1.01 (0.94, 1.09)  
Cervical Factors only 1.34 (0.41, 4.36) 1.49 (0.45, 4.96)  1.45 (0.86, 2.46) 1.52 (0.93, 2.50)  
Combination of Known
factors 1.03 (0.96, 1.11) 1.08 (1.00, 1.16)  1.04 (1.0, 1.09) 1.04 (1.00, 1.09)  
Previous pregnancy   P=0.427   P=0.007
Yes 1.0 1.0  1.0 1.0  
No 0.90 (0.97, 0.94) 0.99 (0.94, 1.03)  0.96 (0.94, 0.99) 0.97 (0.94, 1.00)  
Number of embryos
transferred   P<0.001   P<0.001
One 1.24 (1.14, 1.35) 1.17 (1.07, 1.28)  0.78 (0.72, 0.83) 0.79 (0.73, 0.85)  
Two 1.0 1.0  1.0 1.0  
Three/four 1.29 (1.20, 1.39) 1.06 (0.98, 1.15)  1.15 (1.10, 1.20) 1.11 (1.06, 1.17)  
Number of oocytes
retrieved   P<0.001   P=0.227
1-4 oocytes 1.29 (1.20, 1.39) 1.20 (1.11, 1.30)  0.95 (0.90, 1.0) 0.98 (0.93, 1.04)  
5-9 oocytes 1.13 (1.08, 1.19) 1.11 (1.05, 1.17)  1.0 (0.97, 1.03) 1.00 (0.96, 1.03)  
10-14 oocytes 1.0 1.0  1.0 1.0  
15-19 oocytes 1.02 (0.95, 1.09) 1.06 (0.99, 1.13)  1.01 (0.98, 1.05) 1.02 (0.98, 1.08)  
20+ oocytes 0.98 (0.91, 1.06) 1.01 (0.93, 1.10)  1.03 (0.98, 1.07) 1.03 (0.98, 1.08)  
Treatment   P=0.128   P=0.572
IVF 1.0 1.0  1.0 1.0  
ICSI 0.96 (0.92, 1.00) 1.04 (0.98, 1.10)  0.96 (0.94, 0.99) 0.99 (0.96, 1.03)  
Embryo Utilisation4   P=0.061   P=0.940
0-25% 0.98 (0.91, 1.04) 1.05 (0.98, 1.13)  1.01 (0.97, 1.05) 0.99 (0.95, 1.04)  
25-50% 1.03 (0.98, 1.08) 1.05 (0.99, 1.11)  1.01 (0.98, 1.05) 1.00 (0.97, 1.03)  
50-75% 0.99 (0.94, 1.05) 1.00 (0.94, 1.07)  1.03 (1.0, 1.07) 1.00 (0.97, 1.04)  
75-100% 1.0 1.0  1.0 1.0  
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and basal FSH. It is worth noting that the association with age
was stronger than that with duration (OR 0.99, [95% CI 0.98,
1.00]). Retrieval of an increased number of oocytes was
associated with higher chances of pregnancy, a finding which
has been reported by others[21,27].
Few large studies are able to report on the predictive power
of embryo quality[7,9,12] and those that do, are inconsistent in
the way embryos are graded. Hunault[7] identified the
morphology score of the two best embryos available for
transfer as a predictor of ongoing pregnancy following single
embryo transfer.
Although the importance of these predictive factors has been
known for some time, their relative importance at each stage of
the treatment, in terms of predicting overall success as well as
the chance of proceeding to the next stage has not been
reported previously. This has been addressed in this study, and
while the factors are the same it is interesting to see how their
influence changes over the course of an IVF cycle. The
association between ICSI and lower risk of treatment failure is
particularly interesting. Previous work[15] has highlighted the
positive association between live birth rates and the use of
ICSI. The role of ICSI appears to be more complex than
previously imagined, as seems to reflect the fact that women
undergoing ICSI have similar prognosis to those undergoing
IVF once women with no oocytes retrieved are no longer
included in the analysis.
Our results suggest that increased female age is a key
determinant of treatment failure - globally as well as at each
stage. Though less pronounced, the influence of duration of
infertility is present at all stages except in the prediction of
fertilisation following insemination or injection of embryos. Lack
of previous pregnancy also has a negative effect all along the
course of treatment up to the point of confirmation of
biochemical pregnancy. Tubal infertility with associated
hydrosalpinx affects the chance of implantation of a transferred
embryo – an observation that has been reported previously and
has been considered to be due to the effect of secretions in the
fallopian tube which may potentially flow into the endometrial
cavity and impair the quality of the deciduas. This effect has
clinical relevance as a Cochrane review has confirmed
doubling of IVF related pregnancy rates after salpingectomy in
women with hydrosalpinges[28].
Clinical implications
The ability to predict chances of pregnancy and livebirth is
critical to decision making around IVF. In cases where the
outcome is in doubt, IVF itself is often seen as a prognostic
exercise which is able to reveal which women are likely to
respond to ovarian stimulation and produce good quality
embryos. The ability to identify factors associated with failure at
each stage of the treatment has the ability to refine decision
making around proceeding with treatment – especially where
the prognosis changes during treatment. For example a 40
year old woman with a poor oocyte yield is more likely to be
unsuccessful than one with a better oocyte yield. This
information can be quantified and can potentially lead to more
sophisticated strategies for individualised decision making such
that women can be counselled appropriately regarding risks of
non pregnancy leading to live birth at each stage.
Research implications.  This strategy opens up the
possibilities of new and more nuanced methods of analyses of
the U.K. national IVF dataset. The ability to link cycles within
women offers an opportunity to develop woman based models
in IVF – with better prediction of cumulative outcomes over a
number of fresh and frozen IVF cycles.
Conclusion
Female age is a key predictor of failure to have a livebirth
following IVF as well as the risk of poor performance at each
stage of treatment. While increased duration of infertility is also
associated with worse outcomes at every stage, its impact
appears to be less influential. Absence of a previous pregnancy
did not impact on ovarian stimulation and pregnancy loss but
does affect the chances of fertilisation and positive pregnancy
test. Women embarking on ICSI treatment for male factor
infertility have a lower chance of treatment failure but this does
not appear to be due to increased chances of implantation of
ICSI embryos.
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Table 6 (continued).
1 Term singleton live birth was defined as a single baby born at 37 weeks or greater gestation
2 Multivariable risk ratio is adjusted for all variables listed in table
3 P values obtained from multivariable model
4 Embryo utilisation was defined as (number of embryos transferred + number of embryos frozen)/total number of embryos created
doi: 10.1371/journal.pone.0082249.t006
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